Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia

Published:2018-07 Issue:4 Volume:20 Page:474-482
ISSN:1525-1578
Container-title:The Journal of Molecular Diagnostics
language:en
Short-container-title:The Journal of Molecular Diagnostics

Author:

Coccaro Nicoletta,Anelli Luisa,Zagaria Antonella,Casieri Paola,Tota Giuseppina,Orsini Paola,Impera Luciana,Minervini Angela,Minervini Crescenzio F.,Cumbo Cosimo,Parciante Elisa,Carluccio Paola,Brunetti Claudia,Specchia Giorgina,Albano Francesco^ORCID

Publisher

Elsevier BV

Subject

Molecular Medicine,Pathology and Forensic Medicine

Reference49 articles.

1. Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia group B experience;Wetzler;Blood,1999

2. The biology and therapy of adult acute lymphoblastic leukemia;Faderl;Cancer,2003

3. Patients' age and BCR-ABL frequency in adult B-precursor ALL: a retrospective analysis from the GMALL study group;Burmeister;Blood,2008

4. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia;van Dongen;Leukemia,1999

5. How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia;Fielding;Blood,2010

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into existing and futuristic treatment approach for chronic myeloid leukaemia;Indian Journal of Medical Research;2024-08-03

2. Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways?;Blood Reviews;2024-08

3. Laboratory validation and clinical utility of next-generation sequencing-based IGH/TCR clonality testing for the monitoring of measurable residual disease in acute lymphoblastic leukaemia: real-world experience at Austin Pathology;Pathology;2024-07

4. MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications;Current Hematologic Malignancy Reports;2024-06-18

5. Is next-generation sequencing the future of measurable residual disease assays for Philadelphia chromosome-positive acute lymphoblastic leukemia?;Expert Review of Hematology;2024-05-14